vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and Simpson Manufacturing Co., Inc. (SSD). Click either name above to swap in a different company.
Simpson Manufacturing Co., Inc. is the larger business by last-quarter revenue ($588.0M vs $397.6M, roughly 1.5× Guardian Pharmacy Services, Inc.). Simpson Manufacturing Co., Inc. runs the higher net margin — 15.0% vs 5.3%, a 9.7% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Simpson Manufacturing Company is a leading building materials manufacturer in the United States that produces structural connectors, fasteners, anchors, and products for new construction and retrofitting.
GRDN vs SSD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $397.6M | $588.0M |
| Net Profit | $20.9M | $88.2M |
| Gross Margin | 21.5% | 45.2% |
| Operating Margin | 7.7% | 19.5% |
| Net Margin | 5.3% | 15.0% |
| Revenue YoY | — | 9.1% |
| Net Profit YoY | — | 13.3% |
| EPS (diluted) | — | $2.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $588.0M | ||
| Q4 25 | $397.6M | $539.3M | ||
| Q3 25 | $377.4M | $623.5M | ||
| Q2 25 | $344.3M | $631.1M | ||
| Q1 25 | $329.3M | $538.9M | ||
| Q4 24 | — | $517.4M | ||
| Q3 24 | $314.4M | $587.2M | ||
| Q2 24 | — | $597.0M |
| Q1 26 | — | $88.2M | ||
| Q4 25 | $20.9M | $56.2M | ||
| Q3 25 | $9.8M | $107.4M | ||
| Q2 25 | $9.0M | $103.5M | ||
| Q1 25 | $9.4M | $77.9M | ||
| Q4 24 | — | $55.4M | ||
| Q3 24 | $-122.0M | $93.5M | ||
| Q2 24 | — | $97.8M |
| Q1 26 | — | 45.2% | ||
| Q4 25 | 21.5% | 43.4% | ||
| Q3 25 | 19.8% | 46.4% | ||
| Q2 25 | 19.8% | 46.7% | ||
| Q1 25 | 19.5% | 46.8% | ||
| Q4 24 | — | 44.0% | ||
| Q3 24 | 19.4% | 46.8% | ||
| Q2 24 | — | 46.7% |
| Q1 26 | — | 19.5% | ||
| Q4 25 | 7.7% | 13.9% | ||
| Q3 25 | 4.3% | 22.6% | ||
| Q2 25 | 3.7% | 22.2% | ||
| Q1 25 | 3.9% | 19.0% | ||
| Q4 24 | — | 14.8% | ||
| Q3 24 | -33.3% | 21.3% | ||
| Q2 24 | — | 22.1% |
| Q1 26 | — | 15.0% | ||
| Q4 25 | 5.3% | 10.4% | ||
| Q3 25 | 2.6% | 17.2% | ||
| Q2 25 | 2.6% | 16.4% | ||
| Q1 25 | 2.9% | 14.5% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | -38.8% | 15.9% | ||
| Q2 24 | — | 16.4% |
| Q1 26 | — | $2.13 | ||
| Q4 25 | — | $1.34 | ||
| Q3 25 | — | $2.58 | ||
| Q2 25 | — | $2.47 | ||
| Q1 25 | — | $1.85 | ||
| Q4 24 | — | $1.31 | ||
| Q3 24 | — | $2.21 | ||
| Q2 24 | — | $2.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $341.0M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $217.9M | $2.1B |
| Total Assets | $412.7M | $3.0B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $341.0M | ||
| Q4 25 | $65.6M | $384.1M | ||
| Q3 25 | $36.5M | $297.3M | ||
| Q2 25 | $18.8M | $190.4M | ||
| Q1 25 | $14.0M | $150.3M | ||
| Q4 24 | — | $239.4M | ||
| Q3 24 | $37.2M | $339.4M | ||
| Q2 24 | — | $354.9M |
| Q1 26 | — | — | ||
| Q4 25 | $0 | $300.0M | ||
| Q3 25 | — | $371.3M | ||
| Q2 25 | — | $376.9M | ||
| Q1 25 | — | $382.5M | ||
| Q4 24 | — | $388.1M | ||
| Q3 24 | $34.3M | $393.8M | ||
| Q2 24 | — | $399.4M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $217.9M | $2.0B | ||
| Q3 25 | $195.5M | $2.0B | ||
| Q2 25 | $179.7M | $1.9B | ||
| Q1 25 | $163.2M | $1.9B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | $133.9M | $1.9B | ||
| Q2 24 | — | $1.8B |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $412.7M | $3.1B | ||
| Q3 25 | $390.0M | $3.0B | ||
| Q2 25 | $356.3M | $3.0B | ||
| Q1 25 | $334.0M | $2.8B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | $348.0M | $2.9B | ||
| Q2 24 | — | $2.8B |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | 0.15× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | 0.26× | 0.21× | ||
| Q2 24 | — | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $34.6M | $155.7M | ||
| Q3 25 | $28.2M | $170.2M | ||
| Q2 25 | $19.9M | $125.2M | ||
| Q1 25 | $17.6M | $7.6M | ||
| Q4 24 | — | $115.8M | ||
| Q3 24 | — | $103.3M | ||
| Q2 24 | — | $111.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $119.0M | ||
| Q3 25 | $24.2M | $133.9M | ||
| Q2 25 | — | $87.3M | ||
| Q1 25 | — | $-42.6M | ||
| Q4 24 | — | $60.3M | ||
| Q3 24 | — | $58.1M | ||
| Q2 24 | — | $70.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 22.1% | ||
| Q3 25 | 6.4% | 21.5% | ||
| Q2 25 | — | 13.8% | ||
| Q1 25 | — | -7.9% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | 11.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.8% | ||
| Q3 25 | 1.1% | 5.8% | ||
| Q2 25 | — | 6.0% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 6.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.65× | 2.77× | ||
| Q3 25 | 2.87× | 1.58× | ||
| Q2 25 | 2.21× | 1.21× | ||
| Q1 25 | 1.86× | 0.10× | ||
| Q4 24 | — | 2.09× | ||
| Q3 24 | — | 1.10× | ||
| Q2 24 | — | 1.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
